Mistelihoidon        yhteisvaikutus muiden  syöpähoitojen kanssa

Sytostaattihoito

Werthmann PG, Kindermann L, Kienle GS. Chemoimmunotherapy in Advanced Renal Cell Carcinoma: A Case Report of a Long-Term Survivor Adjunctly Treated with Viscum album Extracts. Complementary Medicine Research. March 2019:1-4. DOI:10.1159/000496866 .

Thronicke A, Oei SL, Merkle A, Herbstreit C, Lemmens HP, Grah C, Kröz M, Matthes H and Schad F. Integrative cancer care in a certified Cancer Centre of a German Anthroposophic hospital. Complement Ther Med 2018;40:151-157

Pelzer F, Tröger W and Nat D R. Complementary Treatment with Mistletoe Extracts During Chemotherapy: Safety, Neutropenia, Fever, and Quality of Life Assessed in a Randomized Study. J Altern Complement Med, 2018;24:954-961. DOI: 10.1089/acm.2018.0159 

Kim S, Kim K-C, Lee C. Mistletoe (Viscum album) extract targets Axl to suppress cell proliferation and overcome cisplatin- and erlotinib-resistance in non-small cell lung cancer cells. Phytomedicine 2017;36:183-193. DOI: 10.1016/j.phymed.2017.09.017

Schink M and Dehus O. Effects of mistletoe products on pharmacokinetic drug turnover by inhibition and induction of cytochrome P450 activities. BMC Complement Altern Med, 2017;17:521. DOI: 10.1186/s12906-017-2028-1

 

Mansky PJ, Wallerstedt DB, Sannes TS, Stagl J, Johnson LL, Blackman MR, Grem JL, Swain SM and Monahan BP. NCCAM/NCI Phase 1 Study of Mistletoe Extract and Gemcitabine in Patients with Advanced Solid Tumors. Evid Based Complement Alternat Med. 2013;2013:964592. doi:10.1155/2013/964592. Epub 2013 Oct 27

Doehmer J, Eisenbraun J. Assessment of extracts from mistletoe (Viscumalbum) for herb-drug interaction by inhibition and induction of cytochromeP450 activities. Phytother Res 2012;26:11-7. DOI: 10.1002/ptr.3473

Burkhart J, Walchli C, Heusser P, Weissenstein U, Baumgartner S and  Andres AC. In vitro investigation into the potential of a mistletoe extract to alleviate adverse effects of cyclophosphamide. Altern Ther Health Med. 2010; 16: 40-48

Lange-Lindberg A M, Velasco Garrido M and Busse R. Mistletoe treatments for minimising side effects of anticancer chemotherapy. GMS Health Technol Assess 2006;2:Doc18.

von Hagens C, A Loewe-Mesch, JJ Kuehn, U Abel and I Gerhard (2005). Prospektive kontrollierte nicht randomisierte Machbarkeits-Studie zu einer postoperativen simultanen Mistel-/Chemotherapie bei Patientinnen mit Mammakarzinom - Ergebnisse zu Rekrutierbarkeit, Immunparametern, Lebensqualität und Verträglichkeit. In: Scheer R., Bauer R., Becker H., Fintelmann V., Kemper F.H., Schilcher H. (Hrsg.): "Fortschritte in der Misteltherapie, Aktueller Stand der Forschung und klinische Anwendung", 662 Seiten, KVC Verlag Essen 2005, ISBN 3-933351-49-9. S- 567-578.

Pae HO, Oh GS, Seo WG, Shin MK, Hong SG, Lee HS and Chung HT. Mistletoe lectin synergizes with paclitaxel in human SK-hep1 hepatocarcinoma cells. Immunopharmacol Immunotoxicol 2001;23: 531-540.

Kuttan G and Kuttan R: Reduction of leukopenia in mice by "viscum album" administration during radiation and chemotherapy. Tumori 1993;79:74-76

Sivut päivitetty 04-05-2020

© Suomen Antroposofisen lääketieteen lääkäriyhdistys (SALLY) ry

© Mistelikuvat/Mistletoe-Images: Jürg Buess  – Institut Hiscia, Arlesheim (CH)